Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 19938440)

1.

Optimal investment in HIV prevention programs: more is not always better.

Brandeau ML, Zaric GS.

Health Care Manag Sci. 2009 Mar;12(1):27-37.

2.

Shared investment projects and forecasting errors: setting framework conditions for coordination and sequencing data quality activities.

Leitner S, Brauneis A, Rausch A.

PLoS One. 2015 Mar 24;10(3):e0121362. doi: 10.1371/journal.pone.0121362. eCollection 2015.

3.

Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice.

Fraser N, Kerr CC, Harouna Z, Alhousseini Z, Cheikh N, Gray R, Shattock A, Wilson DP, Haacker M, Shubber Z, Masaki E, Karamoko D, Görgens M.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S213-20. doi: 10.1097/QAI.0000000000000456.

PMID:
25723987
4.

The effect of fight cost structure on fighting behaviour.

Broom M, Johanis M, Rychtář J.

J Math Biol. 2014 Dec 3. [Epub ahead of print]

PMID:
25465400
5.

Long-run savings and investment strategy optimization.

Gerrard R, Guillén M, Nielsen JP, Pérez-Marín AM.

ScientificWorldJournal. 2014 Feb 23;2014:510531. doi: 10.1155/2014/510531. eCollection 2014.

6.

Cost-effectiveness of PrEP in HIV/AIDS control in Zambia: a stochastic league approach.

Nichols BE, Baltussen R, van Dijk JH, Thuma PE, Nouwen JL, Boucher CA, van de Vijver DA.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):221-8. doi: 10.1097/QAI.0000000000000145.

PMID:
24694930
7.

Integrated health programs, health outcomes, and return on investment: measuring workplace health promotion and integrated program effectiveness.

Cherniack M.

J Occup Environ Med. 2013 Dec;55(12 Suppl):S38-45. doi: 10.1097/JOM.0000000000000044. Review.

PMID:
24284755
8.

Employing resource allocation modeling to inform HIV prevention planning for the state of Iowa.

Holtgrave DR, Young PA, Mayer RR, Maulsby C, Kim JJ.

AIDS Educ Prev. 2013 Oct;25(5):423-9. doi: 10.1521/aeap.2013.25.5.423.

PMID:
24059879
9.

Averting HIV infections in New York City: a modeling approach estimating the future impact of additional behavioral and biomedical HIV prevention strategies.

Kessler J, Myers JE, Nucifora KA, Mensah N, Kowalski A, Sweeney M, Toohey C, Khademi A, Shepard C, Cutler B, Braithwaite RS.

PLoS One. 2013 Sep 13;8(9):e73269. doi: 10.1371/journal.pone.0073269. eCollection 2013.

10.

HIV epidemic control-a model for optimal allocation of prevention and treatment resources.

Alistar SS, Long EF, Brandeau ML, Beck EJ.

Health Care Manag Sci. 2014 Jun;17(2):162-81. doi: 10.1007/s10729-013-9240-4. Epub 2013 Jun 23.

11.

Incentives for Optimal Multi-level Allocation of HIV Prevention Resources.

Malvankar MM, Zaric GS.

INFOR. 2011 Nov 1;49(4):241-246.

12.

Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study.

Nichols BE, Boucher CA, van Dijk JH, Thuma PE, Nouwen JL, Baltussen R, van de Wijgert J, Sloot PM, van de Vijver DA.

PLoS One. 2013;8(3):e59549. doi: 10.1371/journal.pone.0059549. Epub 2013 Mar 18.

13.

Estimating the impact of state budget cuts and redirection of prevention resources on the HIV epidemic in 59 California local health departments.

Lin F, Lasry A, Sansom SL, Wolitski RJ.

PLoS One. 2013;8(3):e55713. doi: 10.1371/journal.pone.0055713. Epub 2013 Mar 8.

14.

The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis.

Cremin I, Alsallaq R, Dybul M, Piot P, Garnett G, Hallett TB.

AIDS. 2013 Jan 28;27(3):447-58. doi: 10.1097/QAD.0b013e32835ca2dd.

PMID:
23296196
15.

The cost-effectiveness and budget impact of Vietnam's methadone maintenance treatment programme in HIV prevention and treatment among injection drug users.

Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, Houston S, Jacobs P.

Glob Public Health. 2012;7(10):1080-94. doi: 10.1080/17441692.2012.736259. Epub 2012 Oct 30.

PMID:
23106230
16.

The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study.

Gomez GB, Borquez A, Caceres CF, Segura ER, Grant RM, Garnett GP, Hallett TB.

PLoS Med. 2012;9(10):e1001323. doi: 10.1371/journal.pmed.1001323. Epub 2012 Oct 9.

17.

Estimating the cost-effectiveness of needle-syringe programs in Australia.

Kwon JA, Anderson J, Kerr CC, Thein HH, Zhang L, Iversen J, Dore GJ, Kaldor JM, Law MG, Maher L, Wilson DP.

AIDS. 2012 Nov 13;26(17):2201-10. doi: 10.1097/QAD.0b013e3283578b5d.

PMID:
22914579
18.

Cost-effectiveness of methadone maintenance therapy as HIV prevention in an Indonesian high-prevalence setting: a mathematical modeling study.

Wammes JJ, Siregar AY, Hidayat T, Raya RP, van Crevel R, van der Ven AJ, Baltussen R.

Int J Drug Policy. 2012 Sep;23(5):358-64. doi: 10.1016/j.drugpo.2012.06.009. Epub 2012 Aug 10.

19.

Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions.

Shrestha RK, Sansom SL, Farnham PG.

J Public Health Manag Pract. 2012 May-Jun;18(3):259-67. doi: 10.1097/PHH.0b013e31822b2077.

PMID:
22473119
20.

Pattern and levels of spending allocated to HIV prevention programs in low- and middle-income countries.

Amico P, Gobet B, Avila-Figueroa C, Aran C, De Lay P.

BMC Public Health. 2012 Mar 21;12:221. doi: 10.1186/1471-2458-12-221.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk